Prelude Therapeutics, Inc. (PRLD)
3.22
+0.10
(+3.21%)
USD |
NASDAQ |
Mar 19, 16:00
3.22
0.00 (0.00%)
After-Hours: 20:00
Prelude Therapeutics Profit Margin (Quarterly) : -291.8% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 18.82% |
| Immunome, Inc. | -- |
| Incyte Corp. | 19.86% |
| Aclaris Therapeutics, Inc. | -1.53K% |
| Relay Therapeutics, Inc. | -784.1% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -113.7% |
| Return on Assets | -74.50% |
| Return on Invested Capital | -94.37% |
| Gross Profit Margin (Quarterly) | 92.59% |
| Operating Margin (Quarterly) | -307.6% |
| Return on Net Operating Assets | -293.7% |